Human B Cell Differentiation Is Characterized by Progressive Remodeling of O-Linked Glycans

Front Immunol. 2018 Dec 14:9:2857. doi: 10.3389/fimmu.2018.02857. eCollection 2018.

Abstract

Germinal centers (GC) are microanatomical niches where B cells proliferate, undergo antibody affinity maturation, and differentiate to long-lived memory B cells and antibody-secreting plasma cells. For decades, GC B cells have been defined by their reactivity to the plant lectin peanut agglutinin (PNA), which binds serine/threonine (O-linked) glycans containing the asialylated disaccharide Gal-β1,3-GalNAc-Ser/Thr (also called T-antigen). In T cells, acquisition of PNA binding by activated T cells and thymocytes has been linked with altered tissue homing patterns, cell signaling, and survival. Yet, in GC B cells, the glycobiological basis and significance of PNA binding remains surprisingly unresolved. Here, we investigated the basis for PNA reactivity of GC B cells. We found that GC B cell binding to PNA is associated with downregulation of the α2,3 sialyltransferase, ST3GAL1 (ST3Gal1), and overexpression of ST3Gal1 was sufficient to reverse PNA binding in B cell lines. Moreover, we found that the primary scaffold for PNA-reactive O-glycans in B cells is the B cell receptor-associated receptor-type tyrosine phosphatase CD45, suggesting a role for altered O-glycosylation in antigen receptor signaling. Consistent with similar reports in T cells, ST3Gal1 overexpression in B cells in vitro induced drastic shortening in O-glycans, which we confirmed by both antibody staining and mass spectrometric O-glycomic analysis. Unexpectedly, ST3Gal1-induced changes in O-glycan length also correlated with altered binding of two glycosylation-sensitive CD45 antibodies, RA3-6B2 (more commonly called B220) and MEM55, which (in humans) have previously been reported to favor binding to naïve/GC subsets and memory/plasmablast subsets, respectively. Analysis of primary B cell binding to B220, MEM55, and several plant lectins suggested that B cell differentiation is accompanied by significant loss of O-glycan complexity, including loss of extended Core 2 O-glycans. To our surprise, decreased O-glycan length from naïve to post-GC fates best correlated not with ST3Gal1, but rather downregulation of the Core 2 branching enzyme GCNT1. Thus, our data suggest that O-glycan remodeling is a feature of B cell differentiation, dually regulated by ST3Gal1 and GCNT1, that ultimately results in expression of distinct O-glycosylation states/CD45 glycoforms at each stage of B cell differentiation.

Keywords: B cell; CD45; GCNT1; PNA; ST3Gal1; glycan; glycosylation; peanut lectin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / cytology
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism
  • Cell Differentiation / genetics
  • Cell Differentiation / immunology*
  • Cell Line, Tumor
  • Cells, Cultured
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Germinal Center / cytology
  • Germinal Center / immunology
  • Germinal Center / metabolism
  • Glycosylation
  • Humans
  • Lectins / immunology
  • Lectins / metabolism
  • Peanut Agglutinin / immunology
  • Peanut Agglutinin / metabolism
  • Polysaccharides / immunology*
  • Polysaccharides / metabolism
  • Sialyltransferases / genetics
  • Sialyltransferases / immunology
  • Sialyltransferases / metabolism
  • Signal Transduction / genetics
  • Signal Transduction / immunology*
  • beta-Galactoside alpha-2,3-Sialyltransferase

Substances

  • Lectins
  • Peanut Agglutinin
  • Polysaccharides
  • Sialyltransferases
  • beta-Galactoside alpha-2,3-Sialyltransferase
  • ST3GAL1 protein, human